EZZ Life Science Holdings Limited (EZZ.AX)
AUD 1.43
(-4.67%)
AUD 1.43
(-4.67%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 9.71 Million AUD | 110.53% |
| 2023 | 4.61 Million AUD | 158.67% |
| 2022 | 1.78 Million AUD | -35.06% |
| 2021 | 2.74 Million AUD | 85.65% |
| 2020 | 1.47 Million AUD | 25.7% |
| 2019 | 1.17 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 746.69 Thousand AUD | -73.91% |
| 2024 Q2 | 1.49 Million AUD | 100.0% |
| 2024 Q4 | 8.22 Million AUD | 0.0% |
| 2024 FY | 9.71 Million AUD | 110.53% |
| 2023 Q2 | 1.75 Million AUD | 98.97% |
| 2023 Q3 | 1.44 Million AUD | -17.41% |
| 2023 Q1 | 881.36 Thousand AUD | -45.96% |
| 2023 FY | 4.61 Million AUD | 158.67% |
| 2023 Q4 | 2.86 Million AUD | 97.58% |
| 2022 Q1 | 58.82 Thousand AUD | -94.26% |
| 2022 FY | 1.78 Million AUD | -35.06% |
| 2022 Q4 | 1.63 Million AUD | 95.76% |
| 2022 Q3 | 833.12 Thousand AUD | 7182.53% |
| 2022 Q2 | 11.44 Thousand AUD | -80.55% |
| 2021 FY | 2.74 Million AUD | 85.65% |
| 2021 Q2 | 1.54 Million AUD | 83.8% |
| 2021 Q3 | 531.53 Thousand AUD | -65.66% |
| 2021 Q4 | 1.02 Million AUD | 92.82% |
| 2021 Q1 | 842.22 Thousand AUD | -10.66% |
| 2020 Q3 | 809.33 Thousand AUD | 50.66% |
| 2020 Q4 | 942.76 Thousand AUD | 16.49% |
| 2020 Q2 | 537.2 Thousand AUD | 100.0% |
| 2020 Q1 | 268.59 Thousand AUD | 0.0% |
| 2020 FY | 1.47 Million AUD | 25.7% |
| 2019 FY | 1.17 Million AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AdAlta Limited | -5.26 Million AUD | 284.67% |
| Acrux Limited | -9.83 Million AUD | 198.806% |
| Actinogen Medical Limited | -12.83 Million AUD | 175.68% |
| AnteoTech Limited | -11.72 Million AUD | 182.859% |
| Argenica Therapeutics Limited | -5.67 Million AUD | 271.332% |
| Arovella Therapeutics Limited | -7.19 Million AUD | 235.083% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | 765.916% |
| Alterity Therapeutics Limited | -19.6 Million AUD | 149.57% |
| Amplia Therapeutics Limited | -4.42 Million AUD | 319.585% |
| Avecho Biotechnology Limited | -4.58 Million AUD | 311.727% |
| Bio-Gene Technology Limited | -3.06 Million AUD | 417.279% |
| Biome Australia Limited | -1.91 Million AUD | 607.859% |
| Biotron Limited | -5.15 Million AUD | 288.628% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | 166.1% |
| BTC Health Limited | 1.05 Million AUD | -820.751% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | 178.934% |
| CSL Limited | 5.64 Billion AUD | 99.828% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 121.688% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 80.23% |
| Cynata Therapeutics Limited | -8.8 Million AUD | 210.316% |
| Dimerix Limited | -25.05 Million AUD | 138.774% |
| Hexima Limited | -1 Million AUD | 1063.228% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | 438.111% |
| Immuron Limited | -5.8 Million AUD | 267.495% |
| Immutep Limited | -44.93 Million AUD | 121.623% |
| Imugene Limited | -140.93 Million AUD | 106.895% |
| Invex Therapeutics Ltd | -2.13 Million AUD | 555.401% |
| Memphasys Limited | -2.7 Million AUD | 459.34% |
| Nanollose Limited | -1.24 Million AUD | 877.434% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 95.7% |
| Noxopharm Limited | -7.53 Million AUD | 228.952% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | 572.467% |
| Nyrada Inc. | -4.56 Million AUD | 313.067% |
| Orthocell Limited | -11.68 Million AUD | 183.182% |
| PharmAust Limited | -6.65 Million AUD | 245.924% |
| Patrys Limited | -3.53 Million AUD | 374.545% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 114.923% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | 234.364% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 235.207% |
| PYC Therapeutics Limited | -38.85 Million AUD | 125.006% |
| Race Oncology Limited | -13.38 Million AUD | 172.617% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 120.582% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | 144.064% |
| Starpharma Holdings Limited | -15.15 Million AUD | 164.098% |
| Telix Pharmaceuticals Limited | - AUD | -Infinity% |
| Tissue Repair Ltd | -4.87 Million AUD | 299.275% |
| Zelira Therapeutics Limited | -5.93 Million AUD | 263.627% |